Cite

HARVARD Citation

    De Cock, E. et al. (n.d.). A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2‐positive early breast cancer. Cancer medicine. pp. 389-397. [Online]. 
  
Back to record